NASDAQ
No price data available for this timeframe.
Quest Diagnostics Incorporated (DGX) has a price/fcf ratio of 14.17x as of Monday, May 25, 2026. This represents a 8.44% decrease compared to its 12-month average of 15.48x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.